ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 471

Early Signs of Diastolic Impairment in Children with Incident Systemic Lupus Erythematosus

Joyce C. Chang1,2, Brian R. White3, Matthew D. Elias3, Rui Xiao4, Andrea M. Knight5,6,7, Pamela F. Weiss8,9,10 and Laura M. Mercer-Rosa3,7, 1Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 3Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, 4Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 5Center for Pediatric Clinical Effectiveness & PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, 6Division of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 7Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 8Center for Clinical Epidemiology and Biostastistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 9Division of Rheumatology, Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, 10Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, Clinical research, Imaging, Pediatric rheumatology and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Pediatric Rheumatology – Clinical Poster I: Lupus, Sjögren’s Disease, and Myositis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The timing and etiology of diastolic impairment in pediatric-onset systemic lupus erythematosus (pSLE) are poorly understood, and the role of screening echocardiography remains unclear. We compared left ventricular diastolic function at pSLE diagnosis with controls and determined the prevalence of abnormal echocardiographic findings.

Methods: Echocardiograms of children with pSLE ages 5-18 years performed within 1 year of diagnosis and age- and sex-matched controls with structurally normal hearts (evaluated for benign murmurs or chest pain during the same period) were re-read by two blinded cardiologists. Baseline characteristics, SLE disease activity index (SLEDAI), and cardiovascular symptoms/signs were abstracted by chart review. Diastolic indices (E/A ratio, e’, E/e’, and isovolumetric relaxation time (IVRT)) were compared using linear mixed effects models adjusted for systemic hypertension. Other abnormalities, including pericardial effusion and valvular disease, were also evaluated. Pearson’s correlation was used to identify factors associated with worse diastolic indices.

Results: 85 children with incident pSLE had baseline echocardiograms, of which 61% were for screening, 15% were for cardiovascular symptoms/signs, and 23% were for other indications. Median time from SLE diagnosis to echocardiogram was 6 days (interquartile range 1-70). Prior glucocorticoid exposure was minimal (Table 1). Diastolic indices were significantly worse in pSLE cases compared to controls (with lower E/A, lower e’, higher E/e’ and longer IVRT) even after adjustment for hypertension (Table 2). 6 pSLE cases (7%) met cutoffs for abnormally low e’ and 32 (47%) had prolonged IVRT, though none met international criteria for Grade I diastolic dysfunction. Mild to moderate pericardial effusions, aortic and mitral insufficiency were present in 15%, 17%, and 6% of all pSLE cases, respectively, including 8%, 15%, and 3% of asymptomatic pSLE cases (n=61). SLE disease activity, but not presence of effusion, was correlated with worse E/e’ (ρ 0.31, p=0.02), septal e’ (-0.30, p<0.01), and IVRT (0.50, p<0.01).

Conclusion: Subclinical echocardiographic findings were prevalent in a group of children with incident SLE, with worse diastolic indices at diagnosis compared to peers without SLE, independent of long-term glucocorticoid use or hypertension. Future longitudinal studies using echocardiography will determine whether these measures of diastolic function worsen over time and if they are prognostic of future cardiac complications.

 

Table 1. Baseline demographic and disease characteristics

pSLE

Controls

p-value

 

(N=85)

(N=85)

 

Age, mean (SD)

14.6 (2.9)

14.6 (2.9)

–

Female, n (%)

68 (80)

68 (80)

–

Race, n (%)

 

 

 

White

50 (59)

28 (33)

<0.01

African American

15 (18)

32 (38)

 

Asian

 6 ( 7)

17 (20)

 

Other

14 (16)

 8 ( 9)

 

Ethnicity, n (%)

Non-Hispanic

76 (89)

68 (80)

0.17

Hispanic

6 ( 7)

11 (13)

Body Mass Index, mean (SD)

21.0 (4.2)

22.0 (4.8)

0.15

Body Surface Area

1.5 (0.3)

1.5 (0.3)

0.85

Hypertension, n (%)

18 (21)

0 (0)

<0.01

Serositis, n (%)

20 (24)

–

–

Nephritis

37 (44)

–

–

Neurologic

 9 (11)

–

–

Antiphospholipid antibodies

51 (60)

–

–

SLEDAI*, mean (SD)

16.8 (9.1)

–

–

Cumulative prednisone dose (mg)¶, median [IQR]

60 [0-1652]

–

–

Duration of prednisone use (days), median [IQR]

0 [0-3]

–

–

Cardiac symptom#, n (%)

24 (28)

–

–

Cardiac exam abnormality^

 9 (11)

–

–

* SLEDAI < 5: low disease activity; 6-10: moderate; 11-19: high; maximum 105

¶ Cumulative oral prednisone dose prior to echocardiogram

# Chest pain, dyspnea, palpitations

^ Murmur, rub, gallop, tachycardia

 

Table 2. Left ventricular diastolic function in pSLE cases versus controls

 

Controls

SLE

Unadjusted

Adjusted for hypertension

 

N = 85

N = 85

 

 

mean (SD)

β*

95% CI

p

β*

95% CI

p

E/A, mitral

2.2 (0.6)

1.9 (0.5)

-0.2

[-0.4, -0.1]

0.01

-0.2

[-0.4, -0.01]

0.04

 

e’ (septal)

12.4 (1.6)

11.4 (2.2)

-1.1

[-1.8, -0.4]

<0.01

-0.9

[-1.7, -0.1]

0.02

 

e’ (lateral)

17.0 (3.2)

14.8 (3.3)

-2.3

[-3.5, -1.1]

<0.01

-1.9

[-3.3, -0.5]

0.01

 

E/e’ (average)

6.6 (1.3)

7.3 (1.7)

 0.9

[ 0.3,  1.5]

0.01

 0.9

[ 0.2,  1.6]

0.02

 

IVRT^

59.8 (12.0)

67.9 (16.7)

 7.0

[ 1.9, 12.2]

0.01

 4.4

[-1.2, 10.0]

0.12

 

Comparison of mean diastolic indices in 85 SLE cases and 85 age and sex-matched controls.

 

Decreased mitral inflow E/A ratio (abnormal <1), decreased tissue Doppler septal e’ (<7 cm/s), decreased lateral e’ (<10 cm/s), elevated E/e’ (>14) and prolonged IVRT (>70 msec) correspond to impaired relaxation.

 

* Mean differences in linear mixed effects models, with or without adjustment for systemic hypertension

 

^ IVRT = isovolumetric relaxation time

 

 


Disclosure: J. C. Chang, None; B. R. White, None; M. D. Elias, None; R. Xiao, None; A. M. Knight, None; P. F. Weiss, Lilly, 5, 9; L. M. Mercer-Rosa, None.

To cite this abstract in AMA style:

Chang JC, White BR, Elias MD, Xiao R, Knight AM, Weiss PF, Mercer-Rosa LM. Early Signs of Diastolic Impairment in Children with Incident Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/early-signs-of-diastolic-impairment-in-children-with-incident-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/early-signs-of-diastolic-impairment-in-children-with-incident-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology